High Growth Tech Stocks In The US To Watch This June 2025

As the U.S. market experiences a positive trend with the S&P 500 and Nasdaq Composite reaching their highest levels since February, investors are buoyed by easing trade tensions between the U.S. and China and encouraging inflation data. In this environment, identifying high-growth tech stocks involves looking for companies that can capitalize on technological advancements while navigating economic shifts effectively.

Top 10 High Growth Tech Companies In The United States

Click here to see the full list of 230 stocks from our US High Growth Tech and AI Stocks screener.

Let's dive into some prime choices out of from the screener.

Exact Sciences (EXAS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Exact Sciences Corporation is involved in the development and commercialization of cancer screening and diagnostic test products, with a market capitalization of approximately $10.31 billion.

Operations: The company generates revenue primarily from its biotechnology segment, which contributed $2.83 billion. It focuses on cancer screening and diagnostic tests both domestically and internationally.

Exact Sciences is making significant strides in the high-growth tech sector, particularly through its advancements in cancer diagnostics. The company's recent presentation at the ASCO Annual Meeting highlighted the Oncodetect™ MRD test, which has shown a remarkable ability to predict cancer recurrence with up to 37-fold increased risk detection. This innovation leverages Broad Institute's MAESTRO technology for enhanced accuracy and scalability, positioning Exact Sciences at the forefront of personalized medicine. Additionally, with a substantial increase in R&D expenses year-over-year by 15%, totaling $320 million, Exact Sciences is committed to maintaining its competitive edge through continuous innovation and development of cutting-edge technologies.

• Navigate through the intricacies of Exact Sciences with our comprehensive health report here.

• Review our historical performance report to gain insights into Exact Sciences''s past performance.

GoodRx Holdings (GDRX)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: GoodRx Holdings, Inc. provides consumers in the United States with tools to compare prices and save on prescription drug purchases, with a market cap of approximately $1.58 billion.

Operations: The company generates revenue primarily through its healthcare software segment, which brought in $797.41 million. With a market cap of approximately $1.58 billion, it focuses on providing tools for price comparison and savings on prescription drugs in the U.S.

GoodRx Holdings, recently profitable with a 26.8% forecasted annual earnings growth, is innovating in the tech-driven healthcare market. Its new subscription service for erectile dysfunction, launched at $18/month, addresses care accessibility by integrating consultations and FDA-approved treatments into a seamless digital experience. Additionally, GoodRx's Community Link initiative supports independent pharmacies with direct pricing control, enhancing their economic stance without traditional intermediaries. These strategic moves not only diversify GoodRx’s revenue streams but also strengthen its position in a competitive sector by aligning closely with consumer and small business needs.

• Take a closer look at GoodRx Holdings' potential here in our health report.

• Learn about GoodRx Holdings' historical performance.

Warner Music Group (WMG)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Warner Music Group Corp. is a global music entertainment company operating in the United States, the United Kingdom, Germany, and internationally, with a market cap of approximately $13.66 billion.

Operations: WMG generates revenue primarily through its Recorded Music segment, contributing $5.11 billion, and its Music Publishing segment, which adds $1.23 billion. The company's operations span multiple regions including the United States, the United Kingdom, and Germany.

Warner Music Group (WMG) is navigating a transformative landscape with strategic initiatives like its recent JV, 5 Junction, aimed at amplifying U.S.-based South Asian artists. This move, alongside the appointment of Armin Zerza as CFO—a veteran with significant experience in tech and entertainment sectors—positions WMG to capitalize on diverse global markets. Despite a slight dip in quarterly sales to $1.48 billion and net income falling to $36 million, WMG's annual revenue growth projection stands at 5.4%, with earnings expected to surge by 20.1% annually. These figures underscore its potential resilience and adaptability in the dynamic entertainment industry.

• Delve into the full analysis health report here for a deeper understanding of Warner Music Group.

• Explore historical data to track Warner Music Group's performance over time in our Past section.

Make It Happen

• Investigate our full lineup of 230 US High Growth Tech and AI Stocks right here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com